Detalhe da pesquisa
1.
Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study.
Prostate
; 77(16): 1550-1562, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28971491
2.
The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo.
Prostate
; 73(5): 489-99, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22996809
3.
PTEN regulation by Akt-EGR1-ARF-PTEN axis.
EMBO J
; 28(1): 21-33, 2009 Jan 07.
Artigo
Inglês
| MEDLINE | ID: mdl-19057511
4.
Propylene Glycol Caprylate-Based Nanoemulsion Formulation of Plumbagin: Development and Characterization of Anticancer Activity.
Biomed Res Int
; 2022: 3549061, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35047632
5.
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo.
Prostate
; 71(8): 813-23, 2011 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21456064
6.
Plumbagin-Serum Albumin Interaction: Spectral, Electrochemical, Structure-Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer Therapy.
ChemMedChem
; 15(14): 1338-1347, 2020 07 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32410390
7.
Is EGR1 a potential target for prostate cancer therapy?
Future Oncol
; 5(7): 993-1003, 2009 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-19792968
8.
Plumbagin-Loaded Nanoemulsion Drug Delivery Formulation and Evaluation of Antiproliferative Effect on Prostate Cancer Cells.
Biomed Res Int
; 2018: 9035452, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30534567
9.
Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo.
Oncogene
; 22(27): 4194-204, 2003 Jul 03.
Artigo
Inglês
| MEDLINE | ID: mdl-12833142
10.
Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses.
J Immunol Methods
; 261(1-2): 177-94, 2002 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-11861076
11.
Antisense to the early growth response-1 gene (Egr-1) inhibits prostate tumor development in TRAMP mice.
Ann N Y Acad Sci
; 1002: 197-216, 2003 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-14751836
12.
Effects of different tissue microenvironments on gene expression in breast cancer cells.
PLoS One
; 9(7): e101160, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25004123
13.
Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer.
PLoS One
; 8(1): e54096, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23342084
14.
Intravital microscopy in the mouse dorsal chamber model for the study of solid tumors.
Am J Cancer Res
; 1(5): 674-86, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21994905
15.
Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway.
J Invest Dermatol
; 127(2): 400-10, 2007 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16960555
16.
Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes.
J Biol Chem
; 278(14): 11802-10, 2003 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-12556466
17.
The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct.
Immunity
; 18(2): 193-204, 2003 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-12594947
18.
Characterization of antigen-specific repertoire diversity following in vitro restimulation by a recombinant adenovirus expressing human cytomegalovirus pp65.
Eur J Immunol
; 33(3): 760-8, 2003 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-12616496